Zacks Investment Research upgraded shares of Victrex (NASDAQ:VTXPF) from a hold rating to a buy rating in a report issued on Thursday. They currently have $30.00 target price on the stock.

According to Zacks, “Victrex Plc engages in the manufacture and marketing of polymers. The company offers products under the Victrex, Aptiv, Vicote and Victrex Pipes brands. It operates through the Victrex Polymer Solutions and Invibio Biomaterial Solutions segments. Victrex Polymer Solutions segment focuses on the automotive, aerospace, electronics and energy markets. Invibio Biomaterial Solutions provides solutions for medical device manufacturers. Victrex Plc is headquartered in Thornton Cleveleys, United Kingdom. “

Victrex (VTXPF) opened at 30.091 on Thursday. Victrex has a 52-week low of $26.10 and a 52-week high of $30.20. The firm has a market capitalization of $2.57 billion and a price-to-earnings ratio of 23.958. The company’s 50-day moving average price is $27.20 and its 200 day moving average price is $27.20.

COPYRIGHT VIOLATION NOTICE: This report was originally published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this report on another website, it was illegally stolen and reposted in violation of U.S. & international trademark and copyright legislation. The legal version of this report can be read at

Get a free copy of the Zacks research report on Victrex (VTXPF)

For more information about research offerings from Zacks Investment Research, visit

Receive News & Stock Ratings for Victrex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Victrex and related stocks with our FREE daily email newsletter.